A detailed history of Baystate Wealth Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Baystate Wealth Management LLC holds 1,201 shares of EW stock, worth $81,379. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,201
Holding current value
$81,379
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$61.71 - $77.76 $74,113 - $93,389
1,201 New
1,201 $91,000
Q2 2023

Aug 02, 2023

BUY
$81.41 - $94.33 $202,141 - $234,221
2,483 New
2,483 $234,000
Q4 2019

Jan 21, 2020

SELL
$71.7 - $82.09 $501 - $574
-7 Closed
0 $0
Q3 2019

Oct 30, 2019

BUY
$61.55 - $75.43 $430 - $528
7 New
7 $2,000
Q1 2018

Apr 24, 2018

SELL
$37.19 - $47.45 $3,198 - $4,080
-86 Closed
0 $0
Q4 2017

Jan 23, 2018

BUY
$33.79 - $39.39 $2,905 - $3,387
86
86 $11,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.